UnknownPhase 2

Effectivity of Mesenchymal Stem Cell on Vertebral Bone Defect Due to Mycobaterium Tuberculosis Infection

Indonesia20 participantsStarted 2017-05-21

Plain-language summary

This study evaluates the effectiveness of locally implantation of mesenchymal stem cell on vertebral bone defects due to infection of mycobacterium tuberculosis. there are controlled participants who receives placebo and patients who receives implantation of MSc

Who can participate

Age range15 Years – 64 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Clinicoradiologically diagnoses Spinal Tuberculosis * receives Anti TB drugs * minimun destruction 1/3 vertebral body Exclusion Criteria: * patient under 15 years old * reject to be included in the study

What they're measuring

Vertebral bony fusion

Timeframe: 1 Year

Trial details

NCT IDNCT04493918

SponsorAhmad Jabir Rahyussalim

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-12-30

Contact for this trial

Ahmad Jabir Rahyussalim, PhD

+62811819466 rahyussalim71@ui.ac.id

View on ClinicalTrials.gov More Spinal Tuberculosis trials